Inhibition of carcinoma cell invasion and liver metastases formation by the cysteine proteinase inhibitor E-64

Clinical and Experimental Metastasis

Volumn 15, Issue 2, 1997, Pages 121-129

  Navab, Roya ^a   Mort, John S ^a   Brodt, Pnina ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

cathepsin; cysteine proteinase; cysteine proteinase proteinase inhibitors; invasion; metastasis

Indexed keywords

CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; MATRIGEL; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CONTROLLED STUDY; FEMALE; LEWIS CARCINOMA; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN;

ANIMALS; CARCINOMA, LEWIS LUNG; CATHEPSIN B; CATHEPSINS; COLLAGEN; CYSTEINE ENDOPEPTIDASES; DRUG COMBINATIONS; DRUG SCREENING ASSAYS, ANTITUMOR; ENDOPEPTIDASES; FEMALE; LAMININ; LEUCINE; LIVER NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0030966971     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018496625936     Document Type: Article

References (38)

1. Liotta LA, Rao CN and Barsky SH, 1983, Tumor invasion and the extracellular matrix. Lab Invest, 49, 636-49.
2. Liotta LA, Steeg PS and Stetler-Stevenson WG, 1991, Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-36.
3. Liotta LA, Tryggvason K, Garbisa S, et al. 1980, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature, 284, 67-8.
4. Murphy G, Reynolds JJ and Hembry RM, 1989, Metalloproteinases and cancer invasion and metastasis. Int J Cancer, 44, 757-60.
5. Mignatti P, Robbins E and Rifkin DB, 1986, Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell, 47, 487-98.
6. Sato H, Takino T, Okada Y, et al. 1994, A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature, 370, 61-5.
7. Brodt P, Reich R, Moroz LA and Chambers AF, 1992, Differences in the repertoires of basement membrane degrading enzymes in two carcinoma sublines with distinct patterns of site-selective metastasis. Biochim Biophys Acta, 1139, 77-83.
8. Barrett AJ, Kembhavi AA, Brown MA, et al. 1982, L-trans-epoxisuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J, 201, 189-98.
9. Umezawa H, 1976, Structures and activities of protease inhibitors of microbial origin. Meth Enzymol, 45, 678-95.
10. Fox T, De Miguel E, Mort JS and Storer AC, 1992, Potent slow-binding inhibition of cathepsin B by its propeptide. Biochemistry, 31, 12571-6.
11. Dipasquale G, Caccese R, Pasternak R, et al. 1986, Proteoglycan and collagen-degrading enzymes from human interleukin (IL-1) stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents. Proc Soc Exp Biol Med, 183, 262-7.
12. Carmichael J, Degraff WG, Gazdar AF, et al. 1987, Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res, 47, 936-42.
13. Chomczynski P and Sacchi N, 1987, Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction. Analyt Biochem, 162, 156-9.
14. Reponen P, Sahlberg C, Huhtala P, et al. 1992, Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J Biol Chem, 267, 7856-62.
15. Feinberg V and Vogelstein BA, 1984, Technique for labelling DNA restriction endonuclease fragments to high specificity. Analyt Biochem, 132, 6-13.
16. Long L, Nip J and Brodt P, 1994, Paracrine growth stimulation by hepatocyte-derived insulin-like growth factor-1: a regulatory mechanism for carcinoma cells metastatic to the liver. Cancer Res, 54, 3732-7.
17. Barrett AJ and Kirschke H, 1981, Cathepsin B, cathepsin H, and cathepsin L. Meth Enzymol, 80, 535-61.
18. Rozhin J, Robinson D, Stevens MA, et al. 1987, Properties of a plasma membrane-associated cathepsin B-like cysteine proteinase in metastatic B16 melanoma variants. Cancer Res, 47, 6620-8.
19. Asao T, Shibata HR, Batist G and Brodt P, 1992, Eradication of hepatic metastases of carcinoma H-59 by combination chemoimmunotherapy with liposomal muramyl tripeptide, 5-fluorouracil, and leucovorin. Cancer Res, 52, 6254-7.
20. Wexler H, 1966, Accurate identification of experimental pulmonary metastases. J Natl Cancer Inst, 36, 641-5.
21. Buck MR, Roth MJ, Zhuang Z, et al. 1994, Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol, 145, 1285-90.
22. Yagel S, Warner AH, Nellans HN, et al. 1989, Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res, 49, 3553-7.
23. Sloane BF, Moin K and Lah TT, 1994, Regulation of lysosomal endopeptidase in malignant neoplasia. In: Pretlow TG and Pretlow TP, eds. Aspects of the Biochemistry and Molecular Biology of Tumors. New York: Academic Press, pp. 411-66.
24. Denhardt DT, Greenberg AH, Egan SE, et al. 1987, Cathepsin L expression correlates closely with the metastatic potential of H-ras-transformed murine fibroblasts. Oncogene, 2, 55-9.
25. Sloane BF, Moin K, Krepela E and Rozhin J, 1990, Cathepsin B and its endogenous inhibitors: the role in tumor malignancy. Cancer Metastasis Rev, 9, 333-52.
26. Sloane BF, Moin K, Sameni M, et al. 1994, Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci, 107, 373-84.
27. Cardozo C, 1992, Degradation of rat lung collagens by cathepsin B. J Lab Clin Med, 119, 169-75.
28. Buck MR, Karustis DG, Day NA, et al. 1992, Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J, 282, 273-8.
29. Sires UI, Schmid TM, Fliszar CJ, et al. 1995, Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin B. J Clin Invest, 95, 2089-95.
30. Kobayashi H, Ohi H, Sugimura M, et al. 1992, Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B. Cancer Res, 52, 3610-14.
31. Mort JS and Recklies AD, 1996, Lysosomal endoproteases, In: Brodt P, ed. Cell Adhesion and Invasion in Cancer Metastasis. Austin, Texas: Springer, pp. 151-64.
32. Velasco G, Ferrando AA, Punete XS, et al. 1994, Human cathepsin D. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues. J Biol Chem, 269, 27136-42.
33. Boike G, Lah T, Sloane BF, et al. 1991, A possible role for cysteine proteinase and its inhibitors in motility of malignant melanoma and other tumour cells. Melanoma Res, 1, 333-40.
34. Redwood MS, Liu BCS, Weiss RE, et al. 1992, Abrogation of the invasion of human bladder tumor cells by using protease inhibitor(s). Cancer, 69, 1212-19.
35. Leto G, Pizzolanti G, Tumminello FM and Gebbia N, 1994, Effects of E-64 (cysteine-proteinase inhibitor) and pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors. In Vivo, 8, 231-6.
36. Koop S, MacDonald IC, Luzzi K, et al. 1995, Fate of melanoma cells entering the microcirculation: over 80% survive and extravasate. Cancer Res, 55, 2520-3.
37. Martinez-Hernandez A, 1984, The hepatic extracellular matrix. I. Electron immunohistochemical studies in normal rat liver. Lab Invest, 51, 57-74.
38. Shoji-Kasai Y, Senshu M, Iwashita S and Imahori K, 1988, Thiol protease-specific inhibitor E-64, arrests human epidermoid carcinoma A 431 cells at mitotic metaphase. Proc Natl Acad Sci USA, 85, 146-50.